ALX Oncology Inc. (ALXO) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    ALX Oncology Inc.

    NASDAQ: ALXO · Real-Time Price · USD
    1.22
    0.14 (12.96%)
    At close: Sep 05, 2025, 3:59 PM
    1.17
    -4.04%
    After-hours: Sep 05, 2025, 05:35 PM EDT

    ALX Oncology Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -0.65 -3.98 -3.71 -10.38
    PEG Ratio
    		 0.02 -0.17 -0.08 -0.17
    PS Ratio
    		 n/a n/a n/a n/a
    PB Ratio
    		 0.77 3.37 1.74 2.39
    P/FCF Ratio
    		 -0.71 -4.86 -5.06 -11.86
    P/OCF Ratio
    		 -0.71 -4.91 -5.14 -12.72
    OCF/S Ratio
    		 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 0.09 0.09 0.04 0.00
    Quick Ratio
    		 7.26 5.24 10.19 24.00
    Current Ratio
    		 7.26 5.24 9.57 24.00
    Asset Turnover
    		 n/a n/a n/a n/a
    Interest Coverage
    		 -82.4 -108.8 -535.45 -6.43K
    Return on Equity
    		 -1.19 -0.85 -0.47 -0.23
    Return on Assets
    		 -0.91 -0.66 -0.4 -0.22
    Return on Invested Capital
    		 -1.1 -0.81 -0.45 -0.23
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a

    Add to Watchlist